Q J Med 2000; 93: 825-829
© 2000 Association of Physicians
Immune cytopenias as the presenting finding in primary Sjögren's syndrome
From the Department of Medicine and 1 Hematology Unit, Kaplan Medical Center, Rehovot, and the Hebrew University-Hadassah Medical School, Jerusalem, Israel
Received 28 September 2000 A diagnostic delay of several years in primary Sjögren's syndrome is common, even in patients who present with sicca symptoms. It is much more likely in cases with prominent symptomatic extraglandular involvement. We report on three such patients who presented as Coomb's positive haemolytic anaemia, systemic symptoms with agranulocytosis and gingival bleeding due to immune thrombocytopenia, to alert clinicians to the fact that primary Sjögren's syndrome may present as clinically significant immune-mediated cytopenia in the absence of sicca symptoms. Sjögren's syndrome, a common autoimmune disorder, should be considered in the differential diagnosis of apparently idiopathic cytopenias and actively sought by directed history, Schirmer test and autoantibody screening.
Address correspondence to Professor A. Schattner, Department of Medicine, Kaplan Medical Center, Rehovot 76100, Israel. e-mail: amiMD{at}clalit.org.il
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M Ramos-Casals, A G Tzioufas, and J Font Primary Sjogren's syndrome: new clinical and therapeutic concepts Ann Rheum Dis, March 1, 2005; 64(3): 347 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schattner Simple Is Beautiful: The Neglected Power of Simple Tests Arch Intern Med, November 8, 2004; 164(20): 2198 - 2200. [Full Text] [PDF] |
||||
![]() |
J. Vivancos, M. Vila, A. Serra, J. Loscos, and A. Anguita Failure of G-CSF therapy in neutropenia associated with Sjogren's syndrome Rheumatology, April 1, 2002; 41(4): 471 - 473. [Full Text] [PDF] |
||||
![]() |
A. Klepfish, J. Friedman, Y. Schechter, and A. Schattner Autoimmune neutropenia, thrombocytopenia and Coombs positivity in a patient with primary Sjogren's syndrome Rheumatology, August 1, 2001; 40(8): 948 - 949. [Full Text] [PDF] |
||||


